Chrislieb A. R. Diabetes and hipertensive vascular disease. A111. J. Cardiol. 32:592, 1973.
Reid, D. D., Brett, G. Z., Hamilton, PJ.S., Jarret, R. J., Keen, H. R. G: Cardiores- piratory disease and diabetes among middle aged male civil servants: A stady of screening and intervention. Lancet 1:469, 1974.
Amery A., Birkenhager W. and cois.: Influence of hypolensive drug treatment in elderly hipertensives. In Mild Hypertension from drug triáis to practice (T. Strasser and D. Ganten), 1987. Raven Press. New York.
Shapiro, A. P., Benedek, T. G. and Small, J. L: Effect ofthiazides on carbohidrate metabolism in patients with hypertension. N. Engl. J. Med. 265:1028, 1961.
Dollery, C. T., Pentecost, B. L, Samaan, N. A.: Dmginduced diabetes. Lancet 11:735, 1976.
Podolsky, S. and Pattavina, C. G.: Hyperosmolar non-ketonic diabetic comoa. A complication ofpropanolol therapy. Metabolism 22:685, 1973.
Tuck, M. Treatment of hypertensive diabetic patients. Diabetes Care 11:828, 1988.
Devis, G., Somers, G., Van Obberghens, E., Malaisse, W.J. Calcium antagonists and islet fnnction. I. lnhibition of insulin release by verapamil. Diabetes 24:547, 1975.
Ferriere, M., Lachkar, H., Richard, J.L., Bringer, J., Orsetti, A. and Mizoure, J. Captopril and insulin sensitivity. Aun. Int. Med. 102:143, 1985.
Tolins, J.P., Raij, L. R. Concerns about diabetic nephropathy in the treatment of diabetic hypertensive patients. Ain. J. Med. 87 (Suppl. 6 A): 6A-29S, 1989.
Moser, M. Diuretics in the manegement of hypertension. Med. Clin. North. Am. 71:935, 1987.
Rauramaa, R., Taskinen, E., Seppanen, K. and cois. Effefcts of calcium antagonist treatment on blood pressure, lipoproteins and prostaglandins. Am. J. Med. 84, 93, 1988.
Zawada, E. T. Jr. Metabolic considerations in the approach to diabetic hypertensive patients. Am. J. Med. 87 (Suppl. 6A): 6A-34S, 1989.
Schwartz, G. L. Initial therapy for hypertension - Individualizing care. Mayo Clin. Proc. 65:73, 1990.
